Literature DB >> 10398084

Chromosomal abnormalities in renal cell neoplasms associated with acquired renal cystic disease. A series studied by comparative genomic hybridization and fluorescence in situ hybridization.

J Gronwald1, A S Baur, H Holtgreve-Grez, A Jauch, F Mosimann, P Jichlinski, J P Wauters, T Cremer, L Guillou.   

Abstract

Sporadic renal cell carcinomas (RCCs) display different chromosomal abnormalities according to their morphology; gains of chromosomes 7 and 17 and loss of Y are commonly observed in papillary lesions, whereas loss of 3p sequences and multiple losses of specific chromosomes are found in non-papillary and chromophobe cell carcinomas, respectively. Acquired renal cystic disease (ARCD) is associated with an increased incidence of renal cell tumours, especially papillary lesions. The aim of this study was to examine a series of ARCD-related tumours for chromosomal abnormalities and to compare the findings with those abnormalities commonly observed in sporadic RCCs. Nine tumours from four patients with ARCD were examined using comparative genomic hybridization (CGH) and interphase cytogenetics. Gain of chromosomes 7 and 17 was observed in all four papillary lesions and loss of Y in three. In addition, gain of chromosome 16 was observed in three papillary tumours. Three chromophobe RCCs originating from the same kidney showed different genomic profiles; two had no abnormalities, whereas one showed loss of chromosome 17p. Two non-papillary RCCs failed to show chromosome 3p alterations. In conclusion, renal cell tumours developing in ARCD may show chromosomal abnormalities both similar to and different from those seen in sporadic tumours.

Entities:  

Mesh:

Year:  1999        PMID: 10398084     DOI: 10.1002/(SICI)1096-9896(199902)187:3<308::AID-PATH256>3.0.CO;2-E

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  4 in total

1.  Genomic profiling of renal cell carcinoma in patients with end-stage renal disease.

Authors:  Toru Inoue; Keiko Matsuura; Taichiro Yoshimoto; Lam Tung Nguyen; Yoshiyuki Tsukamoto; Chisato Nakada; Naoki Hijiya; Takahiro Narimatsu; Takeo Nomura; Fuminori Sato; Yoji Nagashima; Kenji Kashima; Shingo Hatakeyama; Chikara Ohyama; Kazuyuki Numakura; Tomonori Habuchi; Masayuki Nakagawa; Masao Seto; Hiromitsu Mimata; Masatsugu Moriyama
Journal:  Cancer Sci       Date:  2012-01-20       Impact factor: 6.716

2.  Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y.

Authors:  Naoto Kuroda; Tomoyuki Shiotsu; Ondrej Hes; Michal Michal; Taro Shuin; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2011-01-26       Impact factor: 2.309

3.  End-stage kidney disease: gains of chromosomes 7 and 17 and loss of Y chromosome in non-neoplastic tissue.

Authors:  Ondrej Hes; Radek Síma; Jana Nemcová; Milan Hora; Stela Bulimbasic; Dmitry V Kazakov; Tomás Urge; Tomás Reischig; Miroslav Dvorák; Michal Michal
Journal:  Virchows Arch       Date:  2008-09-16       Impact factor: 4.064

4.  Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma.

Authors:  Till Eichenauer; Navid Shadanpour; Martina Kluth; Cosima Göbel; Sören Weidemann; Christoph Fraune; Franziska Büscheck; Claudia Hube-Magg; Christina Möller-Koop; Roland Dahlem; Margit Fisch; Michael Rink; Silke Riechardt; Eike Burandt; Christian Bernreuther; Sarah Minner; Ronald Simon; Guido Sauter; Waldemar Wilczak; Till Clauditz
Journal:  World J Surg Oncol       Date:  2020-06-13       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.